Recent Finacing
Recent Raise
Nemus Biosciences develops cannabinoid-based therapeutics using University of Mississippi-licensed proprietary technology, exploring natural and synthetic compounds and novel delivery approaches to advance candidates toward clinical-stage testing and partnerships.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor